Oropharyngeal Carcinoma — Trials

Oropharyngeal Carcinoma — Trials · CancerIndex

Clinical trials

Registered studies

297 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 107
Recruiting: 56
Ph III recruiting: 3
Growth YoY: −13.6%
Industry share: 8%
Top sponsor: National Cancer Institute (NCI)
Termination share: 39.6%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (47)

clinicaltrialsPublishedShowing 1–1 of 1 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT07768189	A Study to Evaluate CRB-701 Compared to Investigator's Choice Therapy in Previously Treated Oropharyngeal Squamous Cell Carcinoma(TEMPO-1)	not yet recruiting	Phase 3	260	Corbus Pharmaceuticals Inc.INDUSTRY	3	Aug 31, 2026	clinicaltrials

Data updated 22 days agoSource updated Aug 31, 2026source: clinicaltrials